T. Rowe Price Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-34,451
| Closed | -$210K | – | 3102 |
|
|
2021
Q3 | $210K | Buy |
34,451
+15,393
| +81% | +$95.9K | ﹤0.01% | 2707 |
|
|
2021
Q2 | $157K | Buy |
19,058
+507
| +3% | +$4.31K | ﹤0.01% | 2776 |
|
|
2021
Q1 | $166K | Buy |
+18,551
| New | +$213K | ﹤0.01% | 2730 |
|
|
2020
Q4 | – | Sell |
-16,100
| Closed | -$168K | – | 2747 |
|
|
2020
Q3 | $168K | Buy |
16,100
+687
| +4% | +$8.42K | ﹤0.01% | 2458 |
|
|
2020
Q2 | $203K | Buy |
15,413
+211
| +1% | +$2.19K | ﹤0.01% | 2352 |
|
|
2020
Q1 | $120K | Buy |
+15,202
| New | +$229K | ﹤0.01% | 2395 |
|
|
2018
Q4 | – | Sell |
-15,087
| Closed | -$282K | – | 2608 |
|
|
2018
Q3 | $282K | Buy |
15,087
+3,703
| +33% | +$85.1K | ﹤0.01% | 2375 |
|
|
2018
Q2 | $294K | Buy |
11,384
+36
| +0.3% | +$934 | ﹤0.01% | 2353 |
|
|
2018
Q1 | $254K | Buy |
11,348
+74
| +0.7% | +$1.81K | ﹤0.01% | 2348 |
|
|
2017
Q4 | $282K | Buy |
+11,274
| New | +$276K | ﹤0.01% | 2303 |
|